Skip to content

US · 21 CFR

21 CFR Part 211

Current Good Manufacturing Practice for Finished Pharmaceuticals

eCFR, up to date as of 2026-11-12

Table of contents

  1. 211.1Scope.
  2. 211.3Definitions.
  3. 211.22Responsibilities of quality control unit.
  4. 211.25Personnel qualifications.
  5. 211.28Personnel responsibilities.
  6. 211.34Consultants.
  7. 211.42Design and construction features.
  8. 211.44Lighting.
  9. 211.46Ventilation, air filtration, air heating and cooling.
  10. 211.48Plumbing.
  11. 211.50Sewage and refuse.
  12. 211.52Washing and toilet facilities.
  13. 211.56Sanitation.
  14. 211.58Maintenance.
  15. 211.63Equipment design, size, and location.
  16. 211.65Equipment construction.
  17. 211.67Equipment cleaning and maintenance.
  18. 211.68Automatic, mechanical, and electronic equipment.
  19. 211.72Filters.
  20. 211.80General requirements.
  21. 211.82Receipt and storage of untested components, drug product containers, and closures.
  22. 211.84Testing and approval or rejection of components, drug product containers, and closures.
  23. 211.86Use of approved components, drug product containers, and closures.
  24. 211.87Retesting of approved components, drug product containers, and closures.
  25. 211.89Rejected components, drug product containers, and closures.
  26. 211.94Drug product containers and closures.
  27. 211.100Written procedures; deviations.
  28. 211.101Charge-in of components.
  29. 211.103Calculation of yield.
  30. 211.105Equipment identification.
  31. 211.110Sampling and testing of in-process materials and drug products.
  32. 211.111Time limitations on production.
  33. 211.113Control of microbiological contamination.
  34. 211.115Reprocessing.
  35. 211.122Materials examination and usage criteria.
  36. 211.125Labeling issuance.
  37. 211.130Packaging and labeling operations.
  38. 211.132Tamper-evident packaging requirements for over-the-counter (OTC) human drug products.
  39. 211.134Drug product inspection.
  40. 211.137Expiration dating.
  41. 211.142Warehousing procedures.
  42. 211.150Distribution procedures.
  43. 211.160General requirements.
  44. 211.165Testing and release for distribution.
  45. 211.166Stability testing.
  46. 211.167Special testing requirements.
  47. 211.170Reserve samples.
  48. 211.173Laboratory animals.
  49. 211.176Penicillin contamination.
  50. 211.180General requirements.
  51. 211.182Equipment cleaning and use log.
  52. 211.184Component, drug product container, closure, and labeling records.
  53. 211.186Master production and control records.
  54. 211.188Batch production and control records.
  55. 211.192Production record review.
  56. 211.194Laboratory records.
  57. 211.196Distribution records.
  58. 211.198Complaint files.
  59. 211.204Returned drug products.
  60. 211.208Drug product salvaging.
Cover page and contents (original)

Authority:21 U.S.C. 321, 351, 352, 355, 360b, 360ddd, 360ddd-1, 371, 374; 42 U.S.C. 216, 262, 263a, 264.

Source:43 FR 45077, Sept. 29, 1978, unless otherwise noted.

Source: U.S. Office of the Federal Register / GPO — eCFR · U.S. federal government work — public domain (17 U.S.C. §105). eCFR is an editorial compilation, not an official legal edition of the CFR. · retrieved 2026-11-15

Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.